Literature DB >> 31685465

Early Detection of Hepatitis E Virus Ribavirin Resistance Using Next-Generation Sequencing.

Florian Gerhardt1, Melanie Maier2, U G Liebert2, Uwe Platzbecker3, Song-Yau Wang3, Christian Patrick Papp4, C Thomas Bock4, Thomas Berg1, Florian van Bömmel5.   

Abstract

Entities:  

Keywords:  hepatitis E; ribavirin; viral hepatitis

Mesh：

Substances：

Year:  2019        PMID： 31685465      PMCID： PMC7187607          DOI： 10.1128/AAC.01525-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

1.  EASL Clinical Practice Guidelines on hepatitis E virus infection.

Authors: 
Journal:  J Hepatol       Date:  2018-03-31       Impact factor: 25.083

2.  A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.

Authors:  Yannick Debing; Anett Gisa; Kai Dallmeier; Sven Pischke; Birgit Bremer; Michael Manns; Heiner Wedemeyer; Pothakamuri Venkata Suneetha; Johan Neyts
Journal:  Gastroenterology       Date:  2014-08-30       Impact factor: 22.682

3.  Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.

Authors:  Sebastien Lhomme; Nassim Kamar; Florence Nicot; Jacques Ducos; Michael Bismuth; Valerie Garrigue; Joelle Petitjean-Lecherbonnier; Isabelle Ollivier; Elodie Alessandri-Gradt; Odile Goria; Heidi Barth; Peggy Perrin; Karine Saune; Martine Dubois; Romain Carcenac; Caroline Lefebvre; Nicolas Jeanne; Florence Abravanel; Jacques Izopet
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

4.  Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity.

Authors:  Yannick Debing; Christophe Ramière; Kai Dallmeier; Géraldine Piorkowski; Mary-Anne Trabaud; Fanny Lebossé; Caroline Scholtès; Magali Roche; Catherine Legras-Lachuer; Xavier de Lamballerie; Patrice André; Johan Neyts
Journal:  J Hepatol       Date:  2016-05-09       Impact factor: 25.083

Review 5.  Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.

Authors:  Daniel Todt; Toni Luise Meister; Eike Steinmann
Journal:  Curr Opin Virol       Date:  2018-10-29       Impact factor: 7.090

6.  Ribavirin for chronic hepatitis E virus infection in transplant recipients.

Authors:  Nassim Kamar; Jacques Izopet; Simona Tripon; Michael Bismuth; Sophie Hillaire; Jérôme Dumortier; Sylvie Radenne; Audrey Coilly; Valérie Garrigue; Louis D'Alteroche; Matthias Buchler; Lionel Couzi; Pascal Lebray; Sebastien Dharancy; Anne Minello; Maryvonne Hourmant; Anne-Marie Roque-Afonso; Florence Abravanel; Stanislas Pol; Lionel Rostaing; Vincent Mallet
Journal:  N Engl J Med       Date:  2014-03-20       Impact factor: 91.245

Review 7.  Hepatitis E Virus Mutations: Functional and Clinical Relevance.

Authors:  Hoang van Tong; Nghiem Xuan Hoan; Bo Wang; Heiner Wedemeyer; C-Thomas Bock; Thirumalaisamy P Velavan
Journal:  EBioMedicine       Date:  2016-08-06       Impact factor: 8.143
  7 in total
  1 in total

1.  Advanced sequencing approaches detected insertions of viral and human origin in the viral genome of chronic hepatitis E virus patients.

Authors:  C-Patrick Papp; Paula Biedermann; Dominik Harms; Bo Wang; Marianne Kebelmann; Mira Choi; Johannes Helmuth; Victor M Corman; Andrea Thürmer; Britta Altmann; Patrycja Klink; Jörg Hofmann; C-Thomas Bock
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.